ZNF16
Basic information
Region (hg38): 8:144930358-144950888
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (94 variants)
- not_provided (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZNF16 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000006958.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | |||||
| missense | 86 | 94 | ||||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 86 | 10 | 0 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| ZNF16 | protein_coding | protein_coding | ENST00000276816 | 2 | 20531 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 1.65e-12 | 0.107 | 125690 | 0 | 58 | 125748 | 0.000231 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.122 | 373 | 380 | 0.982 | 0.0000201 | 4569 |
| Missense in Polyphen | 75 | 97.725 | 0.76746 | 1247 | ||
| Synonymous | -0.377 | 145 | 139 | 1.04 | 0.00000746 | 1243 |
| Loss of Function | 0.613 | 20 | 23.2 | 0.863 | 0.00000149 | 275 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000572 | 0.000572 |
| Ashkenazi Jewish | 0.0000992 | 0.0000992 |
| East Asian | 0.000217 | 0.000217 |
| Finnish | 0.0000929 | 0.0000924 |
| European (Non-Finnish) | 0.000274 | 0.000273 |
| Middle Eastern | 0.000217 | 0.000217 |
| South Asian | 0.000229 | 0.000229 |
| Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a transcriptional activator. Promotes cell proliferation by facilitating the cell cycle phase transition from the S to G2/M phase. Involved in both the hemin- and phorbol myristate acetate (PMA)-induced erythroid and megakaryocytic differentiation, respectively. Plays also a role as an inhibitor of cell apoptosis. {ECO:0000269|PubMed:16628192, ECO:0000269|PubMed:19763908, ECO:0000269|PubMed:21874239}.;
Recessive Scores
- pRec
- 0.0948
Intolerance Scores
- loftool
- 0.922
- rvis_EVS
- 0.71
- rvis_percentile_EVS
- 85.82
Haploinsufficiency Scores
- pHI
- 0.133
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.455
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.352
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;cell cycle;positive regulation of cell population proliferation;positive regulation of kinase activity;negative regulation of apoptotic process;positive regulation of erythrocyte differentiation;positive regulation of megakaryocyte differentiation;cell division;positive regulation of cell division;cellular response to sodium dodecyl sulfate;positive regulation of cell cycle phase transition
- Cellular component
- nucleus;nucleolus
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein binding;metal ion binding